넷타겟, NetTargets

NetTargets, Inc CFO Jongho Baek sat down with Proactive at the Biotech Showcase 2020 in San Francisco. The South Korea-based company is a spin out of KAIST, one of South Korea’s top research institutes, and is an early-stage drug discovery and development firm based on AI-enhanced systems biology.

Find more information on Stocktube, where the original article was published.

NetTargets will virtually present at Biotech showcase 2023.

NetTargets will deliver a virtual presentation at Biotech Showcase™ 2023, to be held on 09-11 January (Presentation Schedule : January 09 2023, 2:00 PM(PST)). It will also participate in the virtual partnering meeting on 18-19 January 2023.

01 Dec 2022

NetTargets and Daewoong Therapeutics signed MoU on anticancer drug research collaboration

NetTargets has partnered with Daewoong Therapeutics, for an anticancer drug research collaboration using NetTargets N-Map and N-Cap which are "AI-enhanced systems biology" based drug development platforms.

04 May 2022